PBYI — PUMA BIOTECHNOLOGY INC

Ownership history in VIRTUS ADVISERS, LLC  ·  19 quarters on record

This page tracks every 13F SEC filing in which VIRTUS ADVISERS, LLC reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.76% (2019 Q1)
Avg. % of fund
0.37%
First filed
2016 Q1
Last filed
2025 Q4
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 47,172 — 0% 0.13% $281K $5.95
2025 Q3 ADDED 47,172 +33,355 +241.4% 0.16% $250K $5.31
2025 Q2 REDUCED 13,817 -41,614 -75.1% 0.06% $47K $3.43
2025 Q1 ADDED 55,431 +1,378 +2.5% 0.21% $164K $2.96
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    PBYI price (monthly, adj. close)

Other funds also holding PBYI

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 8.33% GLOBEFLEX CAPITAL L P 3Y 7Y 0.41% Verdad Advisers, LP 3Y 0.38% C2C Wealth Management, LLC 3Y 0.12% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.11% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.1% Round Rock Advisors LLC 3Y 0.09% EntryPoint Capital, LLC 0.08% RITHOLTZ WEALTH MANAGEMENT 3Y 7Y 0.08% Baron Wealth Management LLC 0.06%
← Back to VIRTUS ADVISERS, LLC Holdings